Animal models of COPD: Barriers, successes, and challenges
Authors:
- Joanne L. WrightJWJoanne L. Wright
- Andrew ChurgACAndrew Churg
- 1 October 2008
- journal article
- review article
- Published by Elsevier in Pulmonary Pharmacology & Therapeutics
- Vol. 21 (5) , 696-698
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Interleukin-1β Causes Pulmonary Inflammation, Emphysema, and Airway Remodeling in the Adult Murine LungAmerican Journal of Respiratory Cell and Molecular Biology, 2005
- Different lung responses to cigarette smoke in two strains of mice sensitive to oxidantsEuropean Respiratory Journal, 2005
- Cigarette Smoke Induces Persisting Increases of Vasoactive Mediators in Pulmonary ArteriesAmerican Journal of Respiratory Cell and Molecular Biology, 2004
- The Development of Emphysema in Cigarette Smoke-exposed Mice Is Strain DependentAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Tumor Necrosis Factor-α Drives 70% of Cigarette Smoke–induced Emphysema in the MouseAmerican Journal of Respiratory and Critical Care Medicine, 2004
- COPD exacerbations: definitions and classificationsEuropean Respiratory Journal, 2003
- The pathobiological mechanisms of emphysema models: What do they have in common?Pulmonary Pharmacology & Therapeutics, 2003
- Chronic obstructive pulmonary disease * 3: Experimental animal models of pulmonary emphysemaThorax, 2002
- Acute Cigarette Smoke–Induced Connective Tissue Breakdown Requires both Neutrophils and Macrophage Metalloelastase in MiceAmerican Journal of Respiratory Cell and Molecular Biology, 2002
- Chemokines and Their Receptors Guiding T Lymphocyte Recruitment in Lung InflammationAmerican Journal of Respiratory and Critical Care Medicine, 2001